Vertex, Inc. (NASDAQ: VERX) (“Vertex” or the “Company”), a leading global provider of indirect tax solutions, today announced financial results for its third quarter ended September 30, 2025 and the ...

Vertex Pharmaceuticals reported on Monday that it beat Wall Street estimates for third-quarter results, driven by strong demand for its cystic fibrosis treatments and early contributions from newer ...

BOSTON (AP) — BOSTON (AP) — Vertex Pharmaceuticals Inc. (VRTX) on Monday reported third-quarter net income of $1.08 billion. On a per-share basis, the Boston-based company said it had profit of $4.20.

Vertex, Inc. shares have plunged over 60% YTD, but valuation is now compelling after a post-earnings dip. Learn more about VERX stock here.

Vertex stock dipped late Monday despite better-than-expected third-quarter metrics and a slight sales guidance boost.

In the U.S., revenue climbed 15%, to $1.98 billion, helped by strong demand and higher pricing for its cystic-fibrosis drugs, the company said. Its Casgevy and Journavx drugs, which treat severe ...

Biotech company Vertex Pharmaceuticals (NASDAQ:VRTX) in Q3 CY2025, with sales up 11% year on year to $3.08 billion. The ...

A philosopher suggests that we don't have to like each other in order to overcome polarization and work together. It turns out both sides recoiled at the expensive and rushed nature of the election.

First, pick your designation of choice. In this case, it’s Google’s Professional Machine Learning Engineer certification. Then look up the exam objectives and make sure they match your career goals ...

Beirut, Lebanon – They wait, smiling mischievously, their eyes bright at the sight of two wrapped Spider-Man notebooks. Ali, the bolder of the two despite being only three years old, tears his open at ...